When I took over ProCompounding Pharmacy, it was losing roughly $50,000 every month. That is not a number anyone can talk around. It shows up in payroll and in vendor conversations, and a team depends on the business staying open.

The pharmacy itself had something worth protecting. It had been serving patients in Johnson City, Tennessee, since 1936. The people were skilled and committed. The compounding work was careful. What was broken was not the craft. It was the operating model wrapped around the craft.

In under 90 days, the pharmacy was profitable. The lesson is not that one person worked hard. Plenty of people work hard inside businesses that keep losing money. The lesson is that we chose three things to focus on and refused to be distracted by everything else.

Where the pharmacy started

Prescriptions arrived by paper fax. Information that mattered lived in manual spreadsheets that one or two people understood. Shipping was limited to a state or two, which meant the pharmacy could only serve prescribers and patients inside a very small footprint. Too often, the pharmacy could not ship to a clinic’s patients.

None of those problems was unusual. Many independent pharmacies run this way for years. The trouble is that each one carries a cost that does not appear on a single line of the financial statements. Faxes create re-keying. Re-keying creates questions. Questions create phone calls. Phone calls pull pharmacists away from pharmacy work. A narrow licensure footprint caps the size of the business no matter how good the work is.

These were not separate annoyances. They were one problem: the pharmacy was built for a local market, and the market for compounding had become national.

What the financial statements did not show

Anyone reading the financial statements that first month would have seen a local pharmacy losing money in a market shaped by mass manufacturing. That reading was not wrong, but it was incomplete.

What I saw was infrastructure that was not being used: a licensed compounding lab, a team that knew how to do careful work, and a name that had been part of Johnson City since 1936. The problem was not what the pharmacy could do. It was how little of that capacity reached the prescribers who needed it.

The advice was to cut costs

Most of the advice the pharmacy received in those first weeks pointed the same way: cut payroll. That is the standard answer for a business losing $50,000 a month. Cut people, cut hours, cut anything that is not nailed down, and hope the losses shrink faster than the business does.

The pharmacy did the opposite. It kept the team and invested in operations: a focus on prescriptions from clinics and digital health programs, licensure in all 50 states and the District of Columbia, and direct software connections to the prescribers it served. Each of those cost money at a time when there was none to spare.

The reasoning was that payroll was not the problem. The people were the asset that made careful compounding possible. The problem was that the business around them ran on paper and could only reach a local market. Cutting the team would have shrunk the pharmacy to fit a broken model. Investing in operations changed the model.

Deciding what to stop doing

The first decisions were about subtraction. Our team was spending hours on work that was slow by nature: pulling pages off the fax machine, calling people one at a time to collect payments, and ringing up single walk-in purchases. Each task felt small. Together they cost more than they brought in.

So we went through the lab and the office and asked the same three questions about every task. Is it slow? Is it on paper? Does it only work for customers who live nearby? If the answer was yes, we either automated it or stopped doing it.

That also meant deciding what kind of pharmacy we were going to be. Competing with national retail chains as a neighborhood store was not a race we could win. We chose to focus on prescriptions from clinics and digital health programs across the country, each one written by a prescriber for an individual patient.

Focus one: smart software connections

Technology for its own sake was never the point. The point was removing steps that do not need a human. When a prescription arrives as a fax, someone has to read it, interpret it, type it and verify it. When it arrives through a connected electronic workflow, much of that transcription simply disappears, and the pharmacist’s attention goes where it belongs: to the professional review of the prescription itself.

We moved away from paper wherever we could and connected intake to the systems the pharmacy already relied on. We replaced spreadsheets with records that the whole team could see. The goal was not a flashy dashboard. The goal was that a question about an order could be answered in seconds by whoever picked up the phone, instead of waiting for the one person who knew which file to open.

That change mattered most for clinics. A clinic or digital health platform that sends a meaningful volume of prescriptions does not want to manage a pharmacy by fax. It wants clean intake, clear status and a partner whose process fits into its own. Building those connections is what made us a realistic option for the organizations we wanted to serve.

In our first 30 days we set one rule for the whole building: if it can’t be automated through software, it won’t scale. Too much of the pharmacy ran on knowledge that lived in a few people’s heads. When one of them was out sick, everything slowed down.

Today, when a prescriber sends a prescription electronically, it comes straight into our pharmacy system for a pharmacist to review. When the preparation is made and packed, the tracking number goes back to the clinic and the patient automatically, without anyone typing an email. Taking the re-keying out also took out the place where transcription errors start.

Focus two: strict compliance

There is a temptation, when a business is losing money, to treat compliance as overhead. That gets it backwards. In compounding, compliance is the product. Prescribers trust a pharmacy because its processes hold up to scrutiny, and that trust is the asset everything else is built on.

We tightened documentation, standardized procedures and treated every inspection as a chance to show our work rather than something to survive. That discipline is also what later made PCAB accreditation and LegitScript certification realistic goals instead of aspirations. A separate article covers what PCAB accreditation involves from the inside, because the work behind it is more concrete than most people expect.

Compliance also turned out to be a commercial advantage in a very practical sense. Serious clinic partners audit the pharmacies they work with. When your records, policies and accreditation posture are ready before they ask, conversations move faster.

Focus three: building toward all 50 states and DC

The biggest strategic decision was licensure. A pharmacy that can ship to a state or two is a local business. A pharmacy licensed in all 50 states and the District of Columbia can serve a prescriber anywhere in the country. That is a different company.

We also paid for that reach before anyone asked for it. We did not wait for a clinic to ask whether we could ship to its patients in a particular state. We spent our own money early, because a platform choosing a pharmacy usually asks once, and “not yet” ends the conversation. Many 503A pharmacies are licensed only in their home state and a few neighbors, and that is where a national program hits a wall.

Getting there was not quick. Each state has its own board of pharmacy, its own application, its own requirements and its own renewal cycle. We expanded state by state, and every new license widened the set of prescribers we could say yes to. Today ProCompounding is licensed in all 50 states and the District of Columbia, and keeping that coverage current is one of the most important operational jobs in the building. The details are in what it actually takes to get licensed in all 50 states and DC.

The reason this matters so much to clinic founders is simple, and it is covered in why 50-state pharmacy licensing is a big deal: if your pharmacy cannot reach your patients, your growth plan has a wall in it.

What the pharmacy said no to

Focus is mostly about refusal. New product lines, new marketing channels and new partnerships can all sound promising. Every hour spent chasing something new is an hour not spent fixing intake, compliance or licensure.

The pharmacy also did not cut corners in the lab to save money. The financial pressure was real, but a compounding pharmacy that weakens its quality processes to survive a bad quarter is trading a short-term problem for a long-term one. We found savings in workflow, not in standards.

And I said no to chasing whatever was trending in compounding that quarter. A short-term trend can bring in revenue for a few months and leave a pharmacy with processes built for the wrong thing.

Working with a business partner

Having someone who will challenge your assumptions, and who is equally committed to the outcome, is one of the most underrated assets in a recovery like this.

Divide the work clearly, meet often and keep the list of priorities short. When something new comes up, ask the same question: does this move the business forward on software, compliance or licensure? If not, it waits.

From 1936 to a national market

In 1936, compounding was simply what a pharmacy did. A pharmacist prepared medications for the patients who walked in, one prescription at a time.

Over the decades that followed, mass manufacturing changed the trade. Most medications arrived finished, in a fixed set of forms, and compounding became the exception rather than the rule. A pharmacy that kept compounding carefully was serving a smaller and smaller share of what its neighbors needed.

Telehealth reversed part of that. Prescribers working across state lines began writing for individual patients whose needs did not fit the finished products on the shelf, and they needed a pharmacy that could prepare the medication and reach the patient wherever they lived. Custom medicine came back, but the market for it was national.

That is the arc this pharmacy sits in. The craft from 1936 is the same. The market it serves is a different size.

Keeping what 1936 got right

Fixing the business never meant throwing away its history. The rules the pharmacy started with in 1936 are still the rules: take good care of people, get the medicine right and keep patients safe.

What changed is everything around those rules. High standards, licensure in all 50 states and the District of Columbia, and software that connects us to the prescribers we serve are what let a pharmacy like this one plan in decades instead of quarters.

Sales gets the partner. Operations keeps them.

Most growth problems in digital health do not start in marketing or sales. They start in operations. Sales gets the partner. Operations keeps them.

A clinic or platform that signs with a pharmacy is really signing for the second month, not the first. The first month is enthusiasm. The second month is whether prescriptions move cleanly, whether a question gets answered by whoever picks up the phone, and whether a patient in a new state can be served without a scramble. That is operations, and it is where the pharmacy put its money.

It is also why the three focus areas were operational rather than commercial. Software connections, compliance and licensure are not what wins a first conversation. They are what keeps a partner after the first month.

What another owner can take from this

If you are running an independent pharmacy that is struggling, start by naming the operating problems underneath the financial one. The losses are the symptom. The causes are usually workflow, reach and trust. Pick a small number of those causes and work on them relentlessly.

If you are looking at buying a heritage healthcare business, look past the loss line. Ask which work only exists because something is still on paper. Ask what it would take, in time and money, to reach the market the business could serve. Ask where the knowledge lives: in records anyone can open, or in the heads of two people. And decide early which standards will not move, no matter how tight the first quarter gets.

Do not underestimate how much of a pharmacy’s cost is hidden in manual work. Do not treat compliance as a tax; treat it as the foundation partners will check. And if your market has become national, build a footprint that matches it, even though the licensing road is long.

ProCompounding today is a different business from the one that was losing $50,000 a month. It still carries a heritage that goes back to 1936, and it still depends on careful pharmacists doing careful work. What changed is the engine around that work. If you want to see what the pharmacy looks like now, visit ProCompounding, or, if you run a clinic or platform, explore a clinic partnership.

COMMON QUESTIONS

How long did it take ProCompounding to become profitable?

Under 90 days. When I acquired the pharmacy it was losing roughly $50,000 a month, and it was profitable before the end of our first quarter.

What were the three decisions behind it?

We cut slow, paper-based and local-only work to focus on prescriptions from clinics and digital health programs nationwide. We paid for licensure in all 50 states and the District of Columbia before clients asked for it. And we replaced knowledge that lived in people’s heads with software connections, from prescription intake to tracking numbers.

Did the pharmacy cut quality standards to save money?

No. We found the savings in workflow, not in standards. The rules the pharmacy has followed since 1936 stayed the same: take good care of people, get the medicine right and keep patients safe.

What should someone ask before buying a struggling heritage pharmacy?

Which work only exists because something is still on paper, what it would take to reach the market the business could serve, where the operating knowledge lives, and which quality standards will not move under financial pressure.

Why not cut payroll when the pharmacy was losing money?

Because the team was the asset, not the cost. The losses came from a model that ran on paper and reached only a local market. The pharmacy kept its people and invested in operations instead: a clinic and digital health focus, licensure in all 50 states and the District of Columbia, and direct software connections to prescribers.

Where do growth problems in digital health usually come from?

Usually from operations, not marketing or sales. Sales brings a partner in. Operations is what keeps them, because a partner stays only if prescriptions move cleanly and patients in every state can be served.